HPLC IN PHARMACOKINETICS AND METABOLISM STUDIES

被引:10
作者
ZECH, K
ARNOLD, P
LIECHTI, H
LUDWIG, G
机构
[1] Research Laboratories of Byk Gulden Pharmaceuticals, Konstanz
关键词
Clanobutin; HPLC; Lonazolac; Metabolism; Pharmacokinetics; Urapidil;
D O I
10.1007/BF02259153
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The use of high-performance liquid chromatography in kinetics and metabolism studies is demonstrated. The following kinetic parameters are ascertained after single oral and intravenous administration of a drug: absorption by areal comparison, elimination constant in the β-phase, and clearance. Concentration levels in serum are measured after repeated oral administration on several days, with pharmacokinetic model fit to estimate limit concentrations in the steady state. Species-dependencies in metabolism are investigated in 24-h urines. The necessary characterization of drug and metabolite peaks is obtained by in-series connection of several detectors. The relative bioavailability of a controlled release form is determined by measuring drug concentrations in the blood. © 1979 Friedr. Vieweg & Sohn Verlagsgesellschaft mbH.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 7 条
[1]  
BECKMANN R, 1966, ARCH INT PHARMACOD T, V160, P161
[2]  
KLEMM K, 1979, ARZNEIMITTEL-FORSCH, V29-1, P1
[3]  
LUDWIG G, 1977, ARZNEIMITTEL-FORSCH, V27-2, P2077
[4]  
Metzler C.M., 1974, USERS MANUAL NONLIN
[5]   INTRASUBJECT VARIATION IN ELIMINATION HALF-LIVES OF DRUGS WHICH ARE APPRECIABLY METABOLIZED [J].
WAGNER, JG .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (02) :165-173
[6]  
WOLD JS, 1972, J PHARMACOL EXP THER, V183, P188
[7]  
ZECH K, 1976, CHROMATOGRAPHIA, V12, P638